Mattel partnered with leading diabetes organization Breakthrough T1D to ensure that the medical devices were accurate The doll, which retails for $10.99, comes with a continuous glucose monitor and ...

Leading diabetes organization Breakthrough T1D partnered with Mattel on the doll to ensure the devices were medically accurate Cara Lynn Shultz is a writer-reporter at PEOPLE. Her work has previously ...

Mattel has created its first Barbie doll with Type 1 diabetes. The toy, which was made in partnership with Breakthrough T1D, features a young woman with an insulin pump, continuous glucose monitor ...

Australian actress Margot Robbie poses on the pink carpet upon arrival for the European premiere of "Barbie" in central London on July 12 Credit: (Photo by JUSTIN TALLIS/AFP via Getty Images) Margot ...

Barbie has worn many hats—literally and figuratively since her debut in 1959. The iconic doll has traveled to space, performed surgery, run for the nation’s highest office and competed in the Olympics ...

Barbie teamed up with nonprofit Breakthrough T1D to bring the doll to life. Barbie is launching its first doll with Type 1 diabetes, Mattel announced Tuesday. The new doll features a continuous ...

Barbie is aiming to expand on inclusivity with the launch of its first doll with Type 1 diabetes. The doll, part of Barbie's Fashionistas line, comes complete with a continuous glucose monitor, ...

The doll comes with medical accessories that many others living with Type 1 diabetes would have. Mattel’s is representing children in a major way by introducing the first-ever Barbie with Type 1 ...

There’s a sense of pride in seeing a Barbie doll that looks like you. Now, children with type 1 diabetes will understand what that feels like. The popular toy manufacturer on Tuesday unveiled the most ...

This Barbie is raising awareness. And they are doing it with the latest addition to Mattel’s inclusive Fashionista Barbie line-up: the first ever doll with type 1 diabetes. And as Mattel emphasized in ...

Lynne Chepulis receives funding from the Health Research Council of New Zealand Anna Serlachius receives funding from the Health Research Council and Breakthrough T1D (formerly JDRF). University of ...